A carregar...
Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease
No treatment until now has directly targeted the mechanisms responsible for the development and growth of cysts in autosomal dominant polycystic kidney disease (ADPKD). Strong rationale and preclinical studies using in vitro and in vivo models justified the launching of two large phase 3 clinical tr...
Na minha lista:
| Publicado no: | Nephrol Dial Transplant |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657439/ https://ncbi.nlm.nih.gov/pubmed/30312438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|